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Albumin nanoemulsions were produced by high pressure homogenization with a tri-block copolymer 
(Poloxamer 407), which presents a central hydrophobic chain of polyoxypropylene (PPO) and two 
identical lateral hydrophilic chains of polyethylene glycol (PEG). We observed a linear correlation 
between tri-block copolymer concentration and size – the use of 5 mg/mL of Poloxamer 407 yields 
nanoemulsions smaller than 100 nm. Molecular dynamics and fluorescent tagging of the tri-block 
copolymer highlight their mechanistic role on the size of emulsions. This novel method enables the 
fabrication of highly stable protein-based emulsions in the nano-size range, highly desirable for 
controlled drug delivery. Folic Acid (FA)-tagged protein nanoemulsions were shown to promote specific 
folate receptor (FR)-mediated targeting in FR positive cells. Carbon monoxide releasing molecule-2 
(CORM-2) was incorporated in the oil phase of the initial formulation. FA-tagged nanoemulsions loaded 
with CORM-2 exhibited a considerable antitumor effect and an increased survival of BALB/c mice bearing 
subcutaneous A20 lymphoma tumors. The developed nanoemulsions also demonstrated to be well 
tolerated by these immunocompetent mice. The novel strategy presented here enables the construction 
of size controlled, functionalized protein-based nanoemulsions with excellent characteristics for active 
targeting in cancer therapy. 
  
